注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Enochian Biosciences Inc是一家临床前阶段的生物科学公司。该公司利用其细胞、基因和免疫治疗技术治疗人类免疫缺陷病毒(HIV)、乙型肝炎病毒(HBV)、流感和冠状病毒感染,并缓解一些非常致命的癌症。该公司的平台包括劫持RNA和同种异体细胞疗法。劫持RNA平台有一种输送机制,可适用于气溶胶(呼吸道感染,如导致新冠肺炎和流感的病毒)和静脉内或其他输送机制(用于乙型肝炎病毒和HIV)。同种异体细胞治疗平台具有人体免疫系统,旨在识别自我并消灭他者或非我,如细菌、病毒和癌细胞。该公司的候选产品包括ENOB-HV-01,它采用细胞和免疫疗法,可以提供预防和治疗HIV的疫苗。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
W. David Hardy | - | 2018 | Chairman of HIV Scientific Advisory Board |
James R. Sapirstein | 62 | 2018 | Independent Director |
Mark R. Dybul | 60 | 2018 | CEO, Director & Member of HBV Scientific Advisory Board |
Gregg Huber Alton | 57 | 2019 | Lead Independent Board Member |
Jayne McNicol | 56 | 2021 | Independent Director |
Carol L. Brosgart | 71 | 2019 | Chairperson of HBV Cure Scientific Advisory Board & Independent Director |
Rene Sindlev | 61 | 2017 | Chairman of the Board |
Steven G. Deeks | - | 2018 | Member of HIV Scientific Advisory Board |
Fabien Zoulim | - | 2020 | Member of HBV Scientific Advisory Board |
Anna Suk-fong Lok | - | 2021 | Member of HBV Scientific Advisory Board |
Richard James Whitley | 78 | 2021 | Member of Respiratory Diseases Scientific Advisory Board |
Peter Revill | - | 2020 | Member of HBV Scientific Advisory Board |
Rudolphus Gabriel Cornelis Hendriks | 77 | 2023 | Independent Director |
Avram C. Miller | 79 | 2023 | Director |
Karen Brink | - | 2024 | Director |
Leni Maria Teuntje Boerner | 61 | 2023 | Independent Director |
Geert Kazemier | - | 2024 | Chairman of Scientific Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核